Monika McClellan

912 total citations
9 papers, 727 citations indexed

About

Monika McClellan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Monika McClellan has authored 9 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Monika McClellan's work include Cancer Cells and Metastasis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer Genomics and Diagnostics (2 papers). Monika McClellan is often cited by papers focused on Cancer Cells and Metastasis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer Genomics and Diagnostics (2 papers). Monika McClellan collaborates with scholars based in Germany. Monika McClellan's co-authors include Péter Fritz, Hiltrud Brauch, Maria Athelogou, Benny K. Abraham, Thomas E. Mürdter, Godehard Friedel, H. Toomes, A. Linder, Bernhard Sperker and Klaus Bosslet and has published in prestigious journals such as Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics and BMC Cancer.

In The Last Decade

Monika McClellan

9 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika McClellan Germany 8 480 300 209 143 85 9 727
Magali Rebucci France 9 410 0.9× 509 1.7× 312 1.5× 125 0.9× 85 1.0× 11 935
Torsten Kroll Germany 16 324 0.7× 301 1.0× 226 1.1× 107 0.7× 88 1.0× 29 717
Mollie H. Wright United States 8 517 1.1× 505 1.7× 184 0.9× 54 0.4× 51 0.6× 10 801
Jesús Anampa United States 7 415 0.9× 242 0.8× 230 1.1× 121 0.8× 92 1.1× 14 746
Hanna Dillekås Norway 4 294 0.6× 308 1.0× 221 1.1× 73 0.5× 90 1.1× 6 702
Sanghyun Lee South Korea 5 439 0.9× 610 2.0× 266 1.3× 92 0.6× 87 1.0× 6 923
Nayoung Jun South Korea 4 440 0.9× 607 2.0× 267 1.3× 92 0.6× 87 1.0× 7 919
Jelena Grahovac Serbia 10 287 0.6× 471 1.6× 227 1.1× 110 0.8× 95 1.1× 21 853
Marina Stantic Australia 12 266 0.6× 449 1.5× 225 1.1× 49 0.3× 56 0.7× 14 699
Nienke A. de Vries Netherlands 12 593 1.2× 436 1.5× 134 0.6× 158 1.1× 76 0.9× 13 1.0k

Countries citing papers authored by Monika McClellan

Since Specialization
Citations

This map shows the geographic impact of Monika McClellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika McClellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika McClellan more than expected).

Fields of papers citing papers by Monika McClellan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika McClellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika McClellan. The network helps show where Monika McClellan may publish in the future.

Co-authorship network of co-authors of Monika McClellan

This figure shows the co-authorship network connecting the top 25 collaborators of Monika McClellan. A scholar is included among the top collaborators of Monika McClellan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika McClellan. Monika McClellan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kuip, Heiko van der, Thomas E. Mürdter, Maike Sonnenberg, et al.. (2006). Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer. 6(1). 86–86. 85 indexed citations
2.
Abraham, Benny K., et al.. (2005). Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis. Clinical Cancer Research. 11(3). 1154–1159. 421 indexed citations
3.
Freiwald, Matthias, Andreas Kirschbaum, Monika McClellan, et al.. (2005). Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Respiratory Research. 6(1). 28 indexed citations
4.
Mürdter, Thomas E., Godehard Friedel, Janne T. Backman, et al.. (2002). Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase. Journal of Pharmacology and Experimental Therapeutics. 301(1). 223–228. 46 indexed citations
5.
Siegle, Isabel, et al.. (2001). Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells.. PubMed. 21(4A). 2687–91. 43 indexed citations
6.
Mürdter, Thomas E., A. Linder, Godehard Friedel, et al.. (2000). Pharmakokinetik von Cyclo-phosphamid, Adriamycin und Adramycin-Prodrug (HMR 1826) im ex-vivo-isolierten perfundierten humanen Lungenresektionsmodell (IHLP)1. Pneumologie. 54(11). 494–498. 5 indexed citations
7.
Bohnenstengel, Frank, Godehard Friedel, Christoph A. Ritter, et al.. (2000). Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation. Cancer Chemotherapy and Pharmacology. 45(1). 63–68. 10 indexed citations
8.
Mürdter, Thomas E., Bernhard Sperker, Monika McClellan, et al.. (1997). Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site.. PubMed. 57(12). 2440–5. 61 indexed citations
9.
Linder, A., Godehard Friedel, Péter Fritz, et al.. (1996). The Ex-Vivo Isolated, Perfused Human Lung Model: Description and Potential Applications. The Thoracic and Cardiovascular Surgeon. 44(3). 140–146. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magali Rebucci Breakdown of academic impact, for papers by Torsten Kroll Breakdown of academic impact, for papers by Mollie H. Wright Breakdown of academic impact, for papers by Jesús Anampa Breakdown of academic impact, for papers by Hanna Dillekås Breakdown of academic impact, for papers by Sanghyun Lee Breakdown of academic impact, for papers by Nayoung Jun Breakdown of academic impact, for papers by Jelena Grahovac Breakdown of academic impact, for papers by Marina Stantic Breakdown of academic impact, for papers by Nienke A. de Vries
Rankless by CCL
2026